BANK OF MONTREAL /CAN/ - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 66 filers reported holding SOLENO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$3,000
-87.0%
2,633
-74.1%
0.00%
Q4 2020$23,000
+228.6%
10,162
+182.7%
0.00%
Q3 2020$7,0000.0%3,595
+3.0%
0.00%
Q2 2020$7,0003,4910.00%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Abingworth LLP 10,302,602$22,769,0006.37%
CVI Holdings, LLC 1,550,960$3,443,0001.28%
ORACLE INVESTMENT MANAGEMENT INC 3,670,384$8,148,0001.03%
Trellus Management Company, LLC 366,432$813,0000.88%
AWM Investment Company, Inc. 1,550,000$3,441,0000.60%
Samsara BioCapital, LLC 750,000$1,665,0000.54%
Nantahala Capital Management 7,426,368$16,487,0000.50%
Consonance Capital Management LP 3,040,000$6,749,0000.40%
SPHERA FUNDS MANAGEMENT LTD. 1,233,676$2,739,0000.26%
Granite Point Capital Management, L.P. 2,200,000$4,884,0000.25%
View complete list of SOLENO THERAPEUTICS INC shareholders